Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
“Today’s decision by the FDA reflects the continued progress in how we understand and treat patients with MASH,…
Solstice adds performance psychologist to team – The Royal Gazette
Created: Jul 25, 2025 03:44 PM (Updated: Jul 25, 2025 03:44 PM) Dale Thomas, a clinical and performance…